Clinical relevance of urokinase-type plasminogen activator, its receptor and inhibitor type 1 in ovarian cancer. - Tecimer,C.; Doering,D.L.; Goldsmith,L.J.; Meyer,J.S.; Abdulhay,G.; Wittliff,J.L. (Int J Gynecol Cancer, 2000)